Induction of tubuloreticular inclusions in human lymphoma cells (Raji line) related to S-phase treatment with halogenated pyrimidines.
D001345:Autoradiography; D001973:Bromodeoxyuridine / Q000008:administration & dosage / Q000494:pharmacology*; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology / Q000648:ultrastructure*; D002455:Cell Division; D002460:Cell Line; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003841:Deoxycytidine / Q000494:pharmacology; D004351:Drug Resistance; D004721:Endoplasmic Reticulum / Q000187:drug effects / Q000648:ultrastructure; D007065:Idoxuridine / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects / Q000648:ultrastructure*; D013936:Thymidine / Q000494:pharmacology
D004273:DNA, Neoplasm; D003841:Deoxycytidine; D001973:Bromodeoxyuridine; D007065:Idoxuridine; D013936:Thymidine